tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:MDNA Stock Latest News

Medicenna to Spotlight Superkine Oncology Pipeline at Global Investor and Scientific Conferences
Company AnnouncementsMedicenna to Spotlight Superkine Oncology Pipeline at Global Investor and Scientific Conferences
8d ago
Medicenna Refreshes Board With Capital Markets and Biotech Leadership Expertise
PremiumCompany Announcements
Medicenna Refreshes Board With Capital Markets and Biotech Leadership Expertise
14d ago
Medicenna Therapeutics reports Q3 EPS (5c) vs. (7c) last year
PremiumThe Fly
Medicenna Therapeutics reports Q3 EPS (5c) vs. (7c) last year
14d ago
Medicenna Therapeutics sees cash runway into 3Q26
PremiumThe Fly
Medicenna Therapeutics sees cash runway into 3Q26
14d ago
Medicenna Therapeutics appoints Richard Sutin, Angelos Georgakis to board
PremiumThe Fly
Medicenna Therapeutics appoints Richard Sutin, Angelos Georgakis to board
14d ago
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
17d ago
Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
Premium
Company Announcements
Medicenna Maps 2026 Milestones as IL-2 Superkine MDNA11 Delivers Promising Cancer Responses
1M ago
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials
Premium
Company Announcements
Medicenna Targets Pivotal 2026 as IL-2 Superkine Programs Advance Toward Registrational Trials
1M ago
Medicenna Therapeutics announces key milestones for 2026
PremiumThe Fly
Medicenna Therapeutics announces key milestones for 2026
1M ago
Medicenna Therapeutics highlights advancements in key programs
PremiumThe Fly
Medicenna Therapeutics highlights advancements in key programs
1M ago
Medicenna’s MDNA11 Shows Promising Results in Advanced Tumor Trials
PremiumCompany Announcements
Medicenna’s MDNA11 Shows Promising Results in Advanced Tumor Trials
3M ago
Medicenna Therapeutics presents updated clinical data on MDNA11
PremiumThe Fly
Medicenna Therapeutics presents updated clinical data on MDNA11
3M ago
MRK
Medicenna Therapeutics to Host Webinar on MDNA11 Clinical Data
PremiumCompany AnnouncementsMedicenna Therapeutics to Host Webinar on MDNA11 Clinical Data
3M ago
Medicenna Therapeutics Reports Q2 2026 Results and Announces Key Developments in Superkine Programs
Premium
Company Announcements
Medicenna Therapeutics Reports Q2 2026 Results and Announces Key Developments in Superkine Programs
4M ago
Medicenna Therapeutics (MDNA) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Medicenna Therapeutics (MDNA) Q2 Earnings Cheat Sheet
4M ago
Medicenna Partners with Fondazione Melanoma Onlus for Pioneering Melanoma Trial
PremiumCompany Announcements
Medicenna Partners with Fondazione Melanoma Onlus for Pioneering Melanoma Trial
4M ago
Medicenna’s MDNA11 Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Medicenna’s MDNA11 Study: A Potential Game-Changer in Cancer Treatment?
4M ago
MDNA
Medicenna to Present Updated MDNA11 Data at ESMO Congress 2025
PremiumCompany Announcements
Medicenna to Present Updated MDNA11 Data at ESMO Congress 2025
4M ago
Medicenna Therapeutics Corp: Positioned for Growth in the PD-1 Bispecific Antibody Market
PremiumRatings
Medicenna Therapeutics Corp: Positioned for Growth in the PD-1 Bispecific Antibody Market
4M ago
Medicenna Therapeutics to Showcase Innovations at Upcoming Conferences
PremiumCompany AnnouncementsMedicenna Therapeutics to Showcase Innovations at Upcoming Conferences
4M ago
Medicenna Therapeutics initiated with a Buy at Lucid Capital
Premium
The Fly
Medicenna Therapeutics initiated with a Buy at Lucid Capital
5M ago
Promising Developments in Medicenna Therapeutics Corp’s ABILITY-1 Trial Justify Buy Rating
Premium
Ratings
Promising Developments in Medicenna Therapeutics Corp’s ABILITY-1 Trial Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >